国邦医药

- 605507

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017 
国邦医药(605507) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入133,870.30534,944.79405,347.68280,972.02141,016.27
营业收入133,870.30534,944.79405,347.68280,972.02141,016.27
二、营业总成本110,009.72465,482.08347,855.36237,583.90117,988.09
营业成本97,146.08409,711.88305,417.07211,747.37103,490.15
营业税金及附加697.513,619.292,311.791,649.38803.12
销售费用1,722.747,419.795,385.133,249.171,534.21
管理费用7,574.6230,308.2922,954.9915,244.827,632.35
财务费用-896.69-4,628.23-4,489.73-4,050.68-157.46
研发费用3,765.4619,051.0716,276.119,743.844,685.73
资产减值损失----------
公允价值变动收益-38.031,034.22--363.75--
投资收益726.901,322.11467.14-144.45231.42
其中:对联营企业和合营企业的投资收益-69.536.05-153.07-28.73-40.88
汇兑收益----------
三、营业利润23,610.5470,226.3556,397.5841,751.6023,055.06
加:营业外收入48.21331.51211.7137.7922.62
减:营业外支出256.39793.00654.23498.77214.37
其中:非流动资产处置损失----------
四、利润总额23,402.3569,764.8655,955.0641,290.6122,863.30
减:所得税费用3,544.488,766.997,189.485,604.983,366.17
五、净利润19,857.8760,997.8748,765.5735,685.6419,497.14
归属于母公司所有者的净利润19,873.1161,246.4148,907.3335,747.0819,462.93
少数股东损益-15.24-248.55-141.75-61.4434.20
六、每股收益
基本每股收益(元/股)0.36001.10000.88000.64000.3500
稀释每股收益(元/股)0.36001.10000.88000.64000.3500
七、其他综合收益----------
八、综合收益总额19,857.8760,997.8748,765.5735,685.6419,497.14
归属于母公司所有者的综合收益总额19,873.1161,246.4148,907.3335,747.0819,462.93
归属于少数股东的综合收益总额-15.24-248.55-141.75-61.4434.20
下载全部历史数据到excel中 返回页顶